Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ACST

Acasti Pharma

$2.00

-0.04 (-1.96%)

07:56
11/26/19
11/26
07:56
11/26/19
07:56
Hot Stocks
Acasti Pharma reports last patient visit in TRILOGY 1 Phase 3 trial of CaPre »

Acasti Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACST

Acasti Pharma

$2.04

0.105 (5.43%)

08:55
11/18/19
11/18
08:55
11/18/19
08:55
Hot Stocks
Acasti Pharma releases preliminary animal data on CaPres mechanism of action »

Acasti Pharma released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACST

Acasti Pharma

$2.15

0.31 (16.85%)

08:00
11/13/19
11/13
08:00
11/13/19
08:00
Hot Stocks
Breaking Hot Stocks news story on Acasti Pharma »

Acasti Pharma says on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ACST

Acasti Pharma

$2.15

0.31 (16.85%)

08:00
11/13/19
11/13
08:00
11/13/19
08:00
Hot Stocks
Breaking Hot Stocks news story on Acasti Pharma »

Acasti Pharma says on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ACST

Acasti Pharma

$2.15

0.31 (16.85%)

07:59
11/13/19
11/13
07:59
11/13/19
07:59
Hot Stocks
Breaking Hot Stocks news story on Acasti Pharma »

Acasti says uncertainty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ACST

Acasti Pharma

$2.15

0.31 (16.85%)

07:58
11/13/19
11/13
07:58
11/13/19
07:58
Hot Stocks
Acasti Pharma sees cash sufficient beyond completion of Phase 3 trials »

Cash and cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ACST

Acasti Pharma

$2.15

0.31 (16.85%)

07:58
11/13/19
11/13
07:58
11/13/19
07:58
Earnings
Acasti Pharma reports Q2 EPS (34c), one est. (16c) »

Jan D'Alvise,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ACST

Acasti Pharma

$2.03

-0.03 (-1.46%)

08:56
11/07/19
11/07
08:56
11/07/19
08:56
Hot Stocks
Acasti Pharma announces publication of CaPre pharmacokinetics study »

Acasti Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

Over a month ago
ACST

Acasti Pharma

$1.95

0.085 (4.57%)

09:16
11/04/19
11/04
09:16
11/04/19
09:16
Hot Stocks
Acasti Pharma partners with Aker BioMarine to supply krill oil for CaPre »

Acasti Pharma Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACST

Acasti Pharma

$1.95

-0.03 (-1.52%)

04:55
10/24/19
10/24
04:55
10/24/19
04:55
Conference/Events
Acasti Pharma management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.